Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases

Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of human hypertension 2023-08, Vol.37 (8), p.609-618
Hauptverfasser: Visniauskas, Bruna, Kilanowski-Doroh, Isabella, Ogola, Benard O., Mcnally, Alexandra B., Horton, Alec C., Imulinde Sugi, Ariane, Lindsey, Sarah H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 618
container_issue 8
container_start_page 609
container_title Journal of human hypertension
container_volume 37
creator Visniauskas, Bruna
Kilanowski-Doroh, Isabella
Ogola, Benard O.
Mcnally, Alexandra B.
Horton, Alec C.
Imulinde Sugi, Ariane
Lindsey, Sarah H.
description Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.
doi_str_mv 10.1038/s41371-022-00771-0
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2731429560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EoqXwBzigSFy4BPzt-IRQVT6kqlzas-U4s7uuEnvxJJX67-uwpRQO9cWW5_HjGb2EvGX0I6Oi-4SSCcNaynlLqVlPz8gxk0a3SnHz_NH5iLxCvKZ0vehekiOhBbOd0sfk4gznkreQ2gmG6GcYmgnCzqeIEzYxNbvbPZQZEsacGp-GJs87KE3wZYj5xmNYRl-aISJ4BHxNXmz8iPDmfj8hV1_PLk-_t-c_v_04_XLeBmnU3LIgpO4sZ8Z2g5eCBxtEoJYqrmXXQ6-V7L2W3GjRb5RWAiq9YYMJhlllxQn5fPDul742HiDNxY9uX-Lky63LPrp_Kynu3DbfOEYts4LLavhwbyj51wI4uyligHH0CfKCjhvBJLdK04q-_w-9zktJdT7HO6msqWsV8gMVSkYssHnohlG35uUOebmal_udl1vV7x7P8fDkT0AVEAcAayltofz9-wntHZcaoMk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2845977774</pqid></control><display><type>article</type><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</creator><creatorcontrib>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</creatorcontrib><description>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</description><identifier>ISSN: 1476-5527</identifier><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/s41371-022-00771-0</identifier><identifier>PMID: 36319856</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>17β-Estradiol ; 631/443/592/75/243 ; 631/443/7 ; Age ; Androgens ; Blood pressure ; Cardiovascular disease ; Cardiovascular diseases ; Cardiovascular Diseases - etiology ; Clinical trials ; Epidemiology ; Estradiol - pharmacology ; Estrogen receptors ; Estrogens ; Female ; Females ; Gender differences ; Health Administration ; Heart failure ; Humans ; Hypertension ; Hypertension - complications ; Hypertension - drug therapy ; Male ; Males ; Medicine ; Medicine &amp; Public Health ; Menopause ; Metabolites ; Nitric oxide ; Public Health ; Receptors, Estrogen ; Receptors, G-Protein-Coupled ; Review Article ; Sex differences ; Smooth muscle ; Stroke ; Womens health</subject><ispartof>Journal of human hypertension, 2023-08, Vol.37 (8), p.609-618</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer Nature Limited.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</citedby><cites>FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</cites><orcidid>0000-0002-4525-2194 ; 0000-0003-4998-8171 ; 0000-0002-9837-4582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,886,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36319856$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Visniauskas, Bruna</creatorcontrib><creatorcontrib>Kilanowski-Doroh, Isabella</creatorcontrib><creatorcontrib>Ogola, Benard O.</creatorcontrib><creatorcontrib>Mcnally, Alexandra B.</creatorcontrib><creatorcontrib>Horton, Alec C.</creatorcontrib><creatorcontrib>Imulinde Sugi, Ariane</creatorcontrib><creatorcontrib>Lindsey, Sarah H.</creatorcontrib><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</description><subject>17β-Estradiol</subject><subject>631/443/592/75/243</subject><subject>631/443/7</subject><subject>Age</subject><subject>Androgens</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Clinical trials</subject><subject>Epidemiology</subject><subject>Estradiol - pharmacology</subject><subject>Estrogen receptors</subject><subject>Estrogens</subject><subject>Female</subject><subject>Females</subject><subject>Gender differences</subject><subject>Health Administration</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Male</subject><subject>Males</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Menopause</subject><subject>Metabolites</subject><subject>Nitric oxide</subject><subject>Public Health</subject><subject>Receptors, Estrogen</subject><subject>Receptors, G-Protein-Coupled</subject><subject>Review Article</subject><subject>Sex differences</subject><subject>Smooth muscle</subject><subject>Stroke</subject><subject>Womens health</subject><issn>1476-5527</issn><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1v1DAQhi0EoqXwBzigSFy4BPzt-IRQVT6kqlzas-U4s7uuEnvxJJX67-uwpRQO9cWW5_HjGb2EvGX0I6Oi-4SSCcNaynlLqVlPz8gxk0a3SnHz_NH5iLxCvKZ0vehekiOhBbOd0sfk4gznkreQ2gmG6GcYmgnCzqeIEzYxNbvbPZQZEsacGp-GJs87KE3wZYj5xmNYRl-aISJ4BHxNXmz8iPDmfj8hV1_PLk-_t-c_v_04_XLeBmnU3LIgpO4sZ8Z2g5eCBxtEoJYqrmXXQ6-V7L2W3GjRb5RWAiq9YYMJhlllxQn5fPDul742HiDNxY9uX-Lky63LPrp_Kynu3DbfOEYts4LLavhwbyj51wI4uyligHH0CfKCjhvBJLdK04q-_w-9zktJdT7HO6msqWsV8gMVSkYssHnohlG35uUOebmal_udl1vV7x7P8fDkT0AVEAcAayltofz9-wntHZcaoMk</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Visniauskas, Bruna</creator><creator>Kilanowski-Doroh, Isabella</creator><creator>Ogola, Benard O.</creator><creator>Mcnally, Alexandra B.</creator><creator>Horton, Alec C.</creator><creator>Imulinde Sugi, Ariane</creator><creator>Lindsey, Sarah H.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4525-2194</orcidid><orcidid>https://orcid.org/0000-0003-4998-8171</orcidid><orcidid>https://orcid.org/0000-0002-9837-4582</orcidid></search><sort><creationdate>20230801</creationdate><title>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</title><author>Visniauskas, Bruna ; Kilanowski-Doroh, Isabella ; Ogola, Benard O. ; Mcnally, Alexandra B. ; Horton, Alec C. ; Imulinde Sugi, Ariane ; Lindsey, Sarah H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-1c3468921798da432c9c3c09052648beb654ba642763bf5653e892f1d7c719593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>17β-Estradiol</topic><topic>631/443/592/75/243</topic><topic>631/443/7</topic><topic>Age</topic><topic>Androgens</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Clinical trials</topic><topic>Epidemiology</topic><topic>Estradiol - pharmacology</topic><topic>Estrogen receptors</topic><topic>Estrogens</topic><topic>Female</topic><topic>Females</topic><topic>Gender differences</topic><topic>Health Administration</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Male</topic><topic>Males</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Menopause</topic><topic>Metabolites</topic><topic>Nitric oxide</topic><topic>Public Health</topic><topic>Receptors, Estrogen</topic><topic>Receptors, G-Protein-Coupled</topic><topic>Review Article</topic><topic>Sex differences</topic><topic>Smooth muscle</topic><topic>Stroke</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Visniauskas, Bruna</creatorcontrib><creatorcontrib>Kilanowski-Doroh, Isabella</creatorcontrib><creatorcontrib>Ogola, Benard O.</creatorcontrib><creatorcontrib>Mcnally, Alexandra B.</creatorcontrib><creatorcontrib>Horton, Alec C.</creatorcontrib><creatorcontrib>Imulinde Sugi, Ariane</creatorcontrib><creatorcontrib>Lindsey, Sarah H.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Visniauskas, Bruna</au><au>Kilanowski-Doroh, Isabella</au><au>Ogola, Benard O.</au><au>Mcnally, Alexandra B.</au><au>Horton, Alec C.</au><au>Imulinde Sugi, Ariane</au><au>Lindsey, Sarah H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>37</volume><issue>8</issue><spage>609</spage><epage>618</epage><pages>609-618</pages><issn>1476-5527</issn><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Cardiovascular disease (CVD) is the leading cause of death globally for men and women. Premenopausal women have a lower incidence of hypertension and other cardiovascular events than men of the same age, but diminished sex differences after menopause implicates 17-beta-estradiol (E2) as a protective agent. The cardioprotective effects of E2 are mediated by nuclear estrogen receptors (ERα and ERβ) and a G protein-coupled estrogen receptor (GPER). This review summarizes both established as well as emerging estrogen-mediated mechanisms that underlie sex differences in the vasculature during hypertension and CVD. In addition, remaining knowledge gaps inherent in the association of sex differences and E2 are identified, which may guide future clinical trials and experimental studies in this field.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36319856</pmid><doi>10.1038/s41371-022-00771-0</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4525-2194</orcidid><orcidid>https://orcid.org/0000-0003-4998-8171</orcidid><orcidid>https://orcid.org/0000-0002-9837-4582</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1476-5527
ispartof Journal of human hypertension, 2023-08, Vol.37 (8), p.609-618
issn 1476-5527
0950-9240
1476-5527
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10919324
source MEDLINE; Alma/SFX Local Collection
subjects 17β-Estradiol
631/443/592/75/243
631/443/7
Age
Androgens
Blood pressure
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - etiology
Clinical trials
Epidemiology
Estradiol - pharmacology
Estrogen receptors
Estrogens
Female
Females
Gender differences
Health Administration
Heart failure
Humans
Hypertension
Hypertension - complications
Hypertension - drug therapy
Male
Males
Medicine
Medicine & Public Health
Menopause
Metabolites
Nitric oxide
Public Health
Receptors, Estrogen
Receptors, G-Protein-Coupled
Review Article
Sex differences
Smooth muscle
Stroke
Womens health
title Estrogen-mediated mechanisms in hypertension and other cardiovascular diseases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T05%3A46%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estrogen-mediated%20mechanisms%20in%20hypertension%20and%20other%20cardiovascular%20diseases&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Visniauskas,%20Bruna&rft.date=2023-08-01&rft.volume=37&rft.issue=8&rft.spage=609&rft.epage=618&rft.pages=609-618&rft.issn=1476-5527&rft.eissn=1476-5527&rft_id=info:doi/10.1038/s41371-022-00771-0&rft_dat=%3Cproquest_pubme%3E2731429560%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2845977774&rft_id=info:pmid/36319856&rfr_iscdi=true